Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer.

Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.

The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor size closely matched body weight and fat levels, suggesting fat reduction may slow ...

Obesity has many adverse effects in patients with breast and other cancers. In this analysis, breast cancer patients randomized to a behavioral weight-loss intervention lost an average of 4.7% of ...

Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment. Now ...

Cancer patients should seek medical advice before using weight-loss injections, a leading UK charity has said. Macmillan Cancer Support urged patients not to view these drugs as “quick fixes,” ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

Please provide your email address to receive an email when new articles are posted on . Remote intervention induced significant weight loss for women with breast cancer and obesity. Weight loss was ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal eClinicalMedicine finds that first generation weight-loss ...

Weight loss drugs, like brand names Wegovy and Zepbound, continue to soar in popularity, and now researchers in Dallas want to know if this class of drugs, GIP/GLP-1 receptor agonists, might be a ...